Wikidata entity: Q410195
C₁₄H₁₇N₃O (P274)

Quantities
| P4250 | defined daily dose | 2.5 |
| P2067 | mass | 243.137162 |
| P3780 | active ingredient in | ... | Q47521638 (???) | ??? |
| P233 | canonical SMILES | String | CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N | ??? |
| P373 | Commons category | String | Frovatriptan | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N | ??? |
| P129 | physically interacts with | ... | Q288797 (5-hydroxytryptamine receptor 1B) | 5-hydroxytryptamine receptor 1B |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q411377 (linezolid) | linezolid |
| P769 | significant drug interaction | ... | Q420685 (rasagiline) | rasagiline |
| P769 | significant drug interaction | ... | Q421934 (moclobemide) | moclobemide |
| P769 | significant drug interaction | ... | Q1747559 (phenelzine) | phenelzine |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q47495783 ((−)-selegiline) | (−)-selegiline |
| P3364 | stereoisomer of | ... | Q82234868 (ent-Frovatriptan) | ent-Frovatriptan |
| P279 | subclass of | ... | Q10705510 (tryptamines) | tryptamines |
| P279 | subclass of | ... | Q55499606 (benzamide) | benzamide |
| P2868 | subject has role | ... | Q7455050 (serotonin receptor agonists) | serotonin receptor agonists |
| P267 | ATC code | N02CC07 |
| P231 | CAS Registry Number | 158747-02-5 |
| P683 | ChEBI ID | 134991 |
| P592 | ChEMBL ID | CHEMBL1279 |
| P661 | ChemSpider ID | 70378 |
| P715 | DrugBank ID | DB00998 |
| P11198 | DrugCentral ID | 1251 |
| P8494 | DSSTOX compound identifier | DTXCID703080 |
| P3117 | DSSTox substance ID | DTXSID0023080 |
| P646 | Freebase ID | /m/0338x5 |
| P595 | Guide to Pharmacology Ligand ID | 7191 |
| P2062 | HSDB ID | 7363 |
| P2057 | Human Metabolome Database ID | HMDB0015133 |
| P234 | InChI | InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1 |
| P235 | InChIKey | XPSQPHWEGNHMSK-SECBINFHSA-N |
| P665 | KEGG ID | D07997 |
| P10245 | MedlinePlus drug identifier | a604013 |
| P486 | MeSH descriptor ID | C108128 |
| P6366 | Microsoft Academic ID (discontinued) | 2777605627 |
| P2115 | NDF-RT ID | N0000148734 |
| P11199 | Probes And Drugs ID | PD009599 |
| P662 | PubChem CID | 77992 |
| P3345 | RxNorm CUI | 228783 |
| P2877 | SureChEMBL ID | 34410 |
| P2892 | UMLS CUI | C0754647 |
| P11089 | UniChem compound ID | 603963 |
| P652 | UNII | H82Q2D5WA7 |
| P11143 | WikiProjectMed ID | Frovatriptan |
Why not click here or view trends?
log id: 2711372